Take-home naloxone training doesn't increase risky drug behaviour

Embargoed until: Publicly released: 2023-08-05 01:00

Australia; NSW; VIC; WA

Photo by NEXT Distro on Unsplash

Take-home naloxone drug training does not appear to increase risky drug behaviour, according to Australian researchers. Naloxone is a medication that can assist in reversing opioid overdose, and there have been concerns providing people who inject drugs with the medication and the training to use it may encourage taking more risks such as injecting more frequently or using drugs alone. The researchers used survey results from a study of injecting drug users in Melbourne to identify people who had take-home naloxone training. They say among 189 people with data before and after their training, there was no change in injecting frequency, benzodiazepine use or amount of time using drugs alone.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: National Drug Research Institute (NDRI), Burnet Institute, National Drug and Alcohol Research Centre (NDARC), Kirby Institute, UNSW Sydney, Monash University, Deakin University, La Trobe University

Funder: The SuperMIX cohort study was funded by the Colonial Foundation Trust and grants 545891 and 1126090 from the NHMRC, with ongoing data collection funded solely by NHMRC.

Media Contact/s

Contact details are only visible to registered journalists.